A glutathione (GSH)-dependent pathway is used for formaldehyde metabolism by a wide variety of prokaryotes and eukaryotes. In this pathway, S-hydroxymethylglutathione, produced by the reaction of formaldehyde with the thiolate moiety of glutathione, is the substrate for a GSH-dependent formaldehyde dehydrogenase (GSH-FDH). While expression of GSH-FDH often increases in the presence of metabolic or exogenous sources of formaldehyde, little is known about the factors that regulate this response. Here, we identify two signal transduction pathways that regulate expression of adhI, the gene encoding GSH-FDH, in Rhodobacter sphaeroides. The loss of the histidine kinase response regulator pair RfdRS or the histidine kinase RfdS increases adhI transcription in the absence of metabolic sources of formaldehyde. Cells lacking RfdRS further increase adhI expression in the presence of metabolic sources of formaldehyde (methanol), suggesting that this negative regulator of GSH-FDH expression does not respond to this compound. In contrast, mutants lacking the histidine kinase response regulator pair AfdRS or the histidine kinase AfdS cannot induce adhI expression in the presence of either formaldehyde or metabolic sources of this compound.
Formaldehyde is a cytogenic compound that is produced by environmental, industrial, and metabolic processes including the oxidative demethylation of amino acids and osmoprotectants or oxidation of one-carbon compounds like methanol, methyl halides, and methane (10, 11, 16, 20-22, 24, 35, 37, 38) . The toxicity of formaldehyde stems from its reactivity with amino and sulfhydryl groups of biological molecules, causing alkylation, mutations, and cross-links that destroy the function of membranes, proteins, and nucleic acids (18, 25) . When the sources of formaldehyde, its toxicity, and the carbon skeletons and reducing power derived from its oxidation are considered, it is clear that cells benefit from metabolism of this compound.
We are studying formaldehyde metabolism by the facultative bacterium Rhodobacter sphaeroides. This ␣-proteobacterium uses a glutathione (GSH)-dependent pathway for formaldehyde metabolism that is similar to those present in several prokaryotic and eukaryotic cells (5, 7) . In this pathway, formaldehyde reacts with the thiolate moiety of GSH to form Shydroxymethylglutathione, a substrate for a GSH-dependent formaldehyde dehydrogenase (GSH-FDH). GSH-FDH oxidizes S-hydroxymethylglutathione to S-formylglutathione with concomitant reduction of NAD. S-Formylglutathione is hydrolyzed to glutathione and formate before oxidation of formate to CO 2 by a NAD-dependent formate dehydrogenase. Evidence supporting the role of GSH-FDH in this pathway includes the inability of GSH-FDH mutants to grow in the presence of metabolic sources of formaldehyde and the defect in formaldehyde oxidation seen in cells that lack this enzyme (5, 19) .
Given this role of GSH-FDH, it makes sense that expression of this enzyme is regulated. In Saccharomyces cerevisiae, GSH-FDH levels are increased by the presence of methylated compounds like methyl methanesulphonate or formaldehyde (36) . In many eubacteria, including R. sphaeroides, expression of the GSH-FDH gene (adhI) is increased when either formaldehyde or metabolic sources of this compound, such as methanol or choline, are present (6, 15, 17) . These and other results led to the proposal that a pathway intermediate, possibly formaldehyde itself, increases adhI transcription. Additional support for the regulated expression of R. sphaeroides GSH-FDH expression includes the existence of mutations, such as the spd-7 allele, that increase adhI transcription (5) . Unfortunately, little molecular information is available on the proteins or signals that regulate expression of GSH-FDH homologs.
To increase our understanding of GSH-FDH expression, we have identified genes that control adhI transcription. In one set of experiments, we utilized a previously characterized mutant containing the spd-7 allele, which increases expression of the adhI-cycI operon (30) . Increased adhI-cycI expression by the spd-7 allele restores photosynthetic growth to a mutant that lacks cytochrome c 2 by increasing levels of the cytochrome c 2 isoform, isocytochrome c 2 , encoded by cycI (31) . By screening for wild-type DNA sequences that abolished photosynthetic growth of cells containing the spd-7 allele, we identified a putative two-component signal transduction system that negatively regulates adhI-cycI transcription, which we termed RfdRS (repressor of formaldehyde dehydrogenase). Mutants lacking RfdRS still increase adhI transcription in response to metabolic sources of formaldehyde, suggesting the presence of additional regulators of adhI transcription. By searching the R. sphaeroides genome sequence, we identified a second related two-component regulatory system, AfdRS (activator of formaldehyde dehydrogenase), that stimulates adhI transcription in vitro and is necessary for formaldehyde-dependent induction of adhI expression in vivo. Both AfdRS and RfdRS display similarity with proteins in the methanol-oxidizing bacterium Paracoccus denitrificans (FlhRS) that have been implicated in controlling the expression of GSH-FDH in that organism. Based on these findings, we propose that R. sphaeroides GSH-FDH expression is positively and negatively regulated. Our data indicate that AfdRS is necessary for formaldehyde-dependent increases in adhI transcription, while negative regulation of adhI transcription by RfdRS responds to a different and unknown signal.
MATERIALS AND METHODS
Strains, plasmids, and growth conditions. Table 1 lists strains and plasmids. R. sphaeroides was grown in Sistrom's minimal medium A containing 35 mM succinate at 30°C (33) . For photosynthetic growth on solid medium, plates were placed in GasPak anaerobic jars (Becton Dickinson Microbiology Systems, Cockeysville, Md.) with H 2 -CO 2 generators. Escherichia coli strain DH5␣ was used as a plasmid host, S17-1 was used for conjugation of plasmids into R. sphaeroides (11) , and ER2566 was used for expression of intein-chitin-binding domain fusions. E. coli strains were typically grown in Luria-Bertani medium at 37°C. When necessary, the medium was supplemented with spectinomycin (25 g/ml), kanamycin (25 g/ml), trimethoprim (30 g/ml), or tetracycline (1 g/ml) for R. sphaeroides and ampicillin (100 g/ml), tetracycline (10 g/ml), spectinomycin (25 g/ml), or kanamycin (25 g/ml) for E. coli. All primer sequences used are available from the authors upon request.
Isolation of sequences that reduce adhI-cycI expression. To identify DNA sequences that reduce expression of the adhI-cycI operon, a cosmid bank of wild-type R. sphaeroides DNA (34) was screened for isolates that abolish photosynthetic growth of a strain, CYCA65R7, that contains the spd-7 allele (30) . E. coli donors were mated with cells containing the spd-7 allele to identify a cosmid, pUI8017, that abolished photosynthetic growth of this strain.
Cloning and inactivation of rfdRTS or afdRTS. To create a strain lacking RfdRTS, an ⍀Sp r cartridge was inserted into codon 23 of the rfdR gene (rfd-1 allele). To do this, a ϳ2.0-kb HindIII fragment containing the ⍀Sp r cartridge was purified from pHP45, and the ends of this fragment were filled in by incubation with the Klenow fragment of DNA polymerase. This fragment was ligated into a filled-in XhoI site of pVW17-4, a plasmid which contains a BamHI fragment encoding rfdR from pUI8017. The resultant plasmid, p⌬RfdR1, was digested with BamHI, and a 3.4-kb fragment carrying the interrupted rfdR gene was purified and its end was filled in. This fragment was ligated into a filled-in EcoRI site of pSUP202. This Tc r Sp r plasmid, p⌬RfdR2, was mobilized into wild-type R. sphaeroides, and colonies exhibiting an Sp r Tc s phenotype were analyzed with genomic Southern blots to ensure that the rfd-1 allele was incorporated by an even number of crossovers (data not shown).
To create a strain lacking RfdS, a ϳ2.2-kb EcoRI fragment containing the last 250 codons of rfdT and the first 459 codons of rfdS was cloned into EcoRIdigested pUC19, generating plasmid pVW17-35. This plasmid was digested with ClaI and StuI and filled in with a Klenow fragment of DNA polymerase, deleting codons 6 to 290 of rfdS. A 2.0-kb SmaI fragment containing the ⍀Sp r cartridge was purified from pHP45 and inserted into this mutant rfdS gene by ligation into digested pVW17-35 (rfd-2 allele). This plasmid, p⌬RfdS1, was digested with EcoRI, and the ϳ4.2-kb fragment containing the R. sphaeroides DNA with the ⍀Sp r cartridge was isolated and ligated into pSUP202 that had been digested with EcoRI. This suicide plasmid, p⌬RfdS2, was introduced into wild-type R. sphaeroides, and mutants were verified as described above.
A 600-bp in-frame deletion in rfdT (codons 71 to 271) was generated by a two-step process. In the first step, PCRs were performed to create products surrounding the region of rfdT to be deleted, each of which contained a 10-bp complementary overlap at the 3Ј end of the upstream product and the 5Јend of the downstream product. These products were mixed in a ϳ1:1 ratio, and a second reaction was performed by using only the outside primers from the first two reactions, resulting in the formation of a ϳ4-kb fragment containing the rfd-3 allele and XbaI sites to facilitate cloning. The product from this second reaction was digested with XbaI, cloned into XbaI-digested pUC19 to generate plasmid pDelT4, and sequenced to confirm the desired in-frame deletion in rfdT. This ϳ4-kb XbaI fragment was cloned into XbaI-digested pCM62. The resultant plasmid, p⌬RfdT1, was mobilized into R. sphaeroides RfdR1 to generate a strain lacking RfdT.
For complementation of the rfdRTS mutants, a ϳ4.6-kb fragment from pUI8017 that contains wild-type rfdRTS was generated by PCR and cloned into XbaI-digested pUC19, generating plasmid pRfd3. This 4.6-kb XbaI fragment was then cloned into XbaI-digested pCM62, generating a plasmid, pRfd4, that was used for complementation analysis.
To clone the afdRTS locus, a ϳ5-kb fragment containing the R. sphaeroides open reading frames RSP2591 (afdR), RSP2593 (afdS), and RSP2592 (afdT) was amplified from genomic DNA, and the PCR product was digested with KpnI, phosphorylated with T4 polynucleotide kinase, and ligated into KpnI-HincIIdigested pUC19, resulting in pAfd1.
To generate a polar insertion in afdR (afd-1 allele), a ϳ1.4-kb region containing this gene was amplified from genomic DNA, placing a KpnI site in the upstream primer. The product was purified, digested with KpnI, phosphorylated, and ligated into HincII-KpnI-digested pUC19, creating pAfdR1. A gene encoding trimethoprim resistance (Tp r ) was inserted into codon 84 of afdR by ligation into BtrI-digested pAfdR1 to generate pDelAfdR1. A ϳ2-kb PCR product was generated from pDelAfdR1 by using vector-specific primers (1224 and 1233) and cloned into ScaI-digested pSup202 to create pDelAfdR3. pDelAfdR3 was conjugated into R. sphaeroides, and strains in which afd-1 had replaced the wild-type gene were verified as described above (strain AfdR7).
To generate a polar insertion in afdS (afd-2 allele), a ϳ2.5-kb region was amplified from genomic DNA, and the product was phosphorylated and ligated into SmaI-digested pUC19 to generate pAfdS1. A BamHI fragment containing a gene encoding Tp r was inserted into codon 142 of afdS by ligation into pAfdS1 that was digested by BglII, forming pDelAfdS1. Plasmid pDelAfdS1 was used to generate a ϳ3.5-kb PCR product containing the afd-2 allele by using vectorspecific primers (1224 and 1233). The product was phosphorylated and ligated into ScaI-digested pSUP202, generating pDelAfdS2. pDelAfdS2 was conjugated into R. sphaeroides, and strains in which afd-2 replaced the wild-type gene were verified as described above (strain AfdS1).
To generate an afdRTS-containing plasmid for complementation, a ϳ5-kb PvuII fragment from pAfd1 was ligated into ScaI-digested pSUP202, resulting in pAfdRTS5. For single-copy complementation, pAfdRTS5 was conjugated into R. sphaeroides, and merodiploids were identified by screening for resistance to both trimethoprim (from the afd-1 or afd-2 allele) and tetracycline (from pSUP202) to generate strains AfdR7-5 and AfdS1-5. The presence of the wild-type afdRTS locus or the afd-1 or afd-2 allele was confirmed by PCR.
Enzyme assays. The levels of ␤-galactosidase activity in aerobic cells containing an adhI::lacZ reporter gene were assayed (31) while cultures were at cell densities of ϳ3.0 ϫ 10 8 to 7.0 ϫ 10 8 CFU/ml. Values reported are averages of data from at least three separate isolates grown in separate cultures. The error reported is the standard deviation between individual isolates (31) . Values for GSH-dependent formaldehyde dehydrogenase activity (7) are the averages of three independent assays. Protein concentration was determined by the Bradford assay (8a).
Western blots. Western blot analysis with antiserum to isocytochrome c 2 (29) was performed on crude cell extracts prepared by sonication of cells from 500-ml cultures grown to a cell density of approximately 10 9 cells per ml by aeration with a gas mixture of 69% N 2 , 30% O 2 , and 1% CO 2 . Equal amounts of crude extract protein (ϳ12.5 g) were loaded on a sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel (4 to 12% gradient) (Invitrogen, Carlsbad, Calif.). Proteins were transferred to nitrocellulose membranes and probed for isocytochrome c 2 with a 1:500 dilution of rabbit antiserum (29) . Secondary anti-rabbit immunoglobulin G conjugated to horseradish peroxidase was used for detection.
Purification of AfdR and RfdR. AfdR or a truncated version of RfdR lacking its presumed N-terminal receiver and oligomerization domains (RfdR-CTD) was purified by using an intein-chitin-binding domain fusion system (New England Biolabs, Beverly, Mass.) that had been previously used to obtain active R. sphaeroides response regulators (9) .
To generate an intein fusion to AfdR, the afdR gene was amplified and cloned into HincII-digested pUC19, generating pAfdR-Int1. After pAfdR-Int1 was digested with NdeI and SmaI, a ϳ750-bp fragment was ligated into pTYB2 that was digested with NdeI and SmaI, forming pAfd-Int2. Before use, pAfd-Int2 was sequenced to ensure that afdR was fused in frame with the intein-chitin-binding domain. To purify AfdR, 1 liter of ER2566 (pAfdR-Int2) cells were grown at 37°C to an optical density at 600 nm of 0.4 to 0.5. IPTG (isopropyl-␤-D-thiogalactopyranoside) was added to 0.3 mM, and the culture was incubated at 30°C for 3 h. Cells were harvested by centrifugation, resuspended in 5 ml of column buffer (20 mM HEPES [pH 8 .0], 250 mM KCl, 0.1 mM EDTA, 0.1% Triton X-100), and To generate an intein fusion to RfdR-CTD, DNA encoding the C-terminal domain (amino acids 150 to 226) was amplified and cloned into SmaI-digested pUC19, generating pMAD1. After pMAD1 was digested with NdeI and SmaI, a ϳ230-bp fragment was ligated into pTYB2 that was digested with NdeI and SmaI, forming pMAD47. Before use, pMAD47 was sequenced to ensure that the C-terminal region of rfdR was fused in frame with the intein-chitin-binding domain. To purify RfdR-CTD, 800 ml of ER2566 (pMAD47) cells were grown at 37°C to an optical density at 600 nm of 0.4 to 0.5. IPTG was added to 0.3 mM, and the culture was incubated at 30°C for 3 h. Cells were harvested by centrifugation, resuspended in 5 ml of column buffer (20 mM Tris-HCl [pH 7.9], 5 mM MgCl 2 , 500 mM KCl, 0.1 mM EDTA, 0.1% Triton X-100), and lysed by sonication. The cell extract was centrifuged at 15,000 ϫ g for 30 min, and the supernatant was loaded onto a 10-ml chitin column equilibrated with 10 column volumes of column buffer. The column was washed with 10 column volumes of column buffer, flushed with column buffer containing 50 mM dithiothreitol, and stored overnight at 4°C to allow intein cleavage. Released protein was eluted in column buffer and collected in 1-ml fractions before analysis by SDS-PAGE. Fractions containing RfdR-CTD were pooled and dialyzed against storage buffer (40 mM Tris-HCl [pH 7.9], 5 mM MgCl 2 , 50 mM KCl, 1 mM dithiothreitol, 20% glycerol).
Gel shift assays. A 476-bp DNA fragment containing the adhI promoter that extends from Ϫ296 to ϩ180 bp relative to the known transcription initiation site (5) was end labeled with [␣-
32 P]ATP. The indicated concentrations of pure recombinant RfdR-CTD were incubated with 2 ng of the end-labeled adhI promoter DNA in a reaction mix containing 10 mM KPO 4 (pH 7.5), 100 mM potassium glutamate, 1 mM EDTA, 0.05 mM dithiothreitol, 0.5 mg of bovine serum albumin/ml, and 30 g of salmon sperm DNA/ml. Binding reactions were incubated at 30°C for 40 min. After incubation, protein-DNA complexes were resolved on a 6% polyacrylamide gel (Invitrogen) by using 0.5ϫ Tris-borate-EDTA as a running buffer. The gel was run at 4°C for 1.5 h at 100 V. The gel was dried and exposed to a PhosphorImager screen overnight and visualized by using a PhosphorImager and ImageQuant software (Molecular Dynamics).
In vitro transcription reactions. A typical 20-l reaction included R. sphaeroides RNA polymerase (9), 20 nM plasmid pJWH20 (see below), and AfdR or RfdR-CTD in transcription buffer (40 mM Tris-Cl [pH 7.9], 50 mM KCl, 5 mM MgCl 2 , 0.2 mM EDTA, 0.1 mM dithiothreitol, 0.1 mg of bovine serum albumin/ ml). This mixture was incubated for 20 min at 30°C prior to initiating the assay. After transcription was initiated by the addition of nucleoside triphosphates (0.5 mM ATP, 0.5 mM GTP, 0.5 mM CTP, and 0.05 mM UTP plus 10 Ci of [␣-32 P]UTP), the reaction mixture was incubated at 30°C for 20 min. Assays were stopped by adding 10 l of loading buffer (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol). Samples were heated to 95°C for 5 min, and the products were separated on a 6% polyacrylamide-urea gel. The gel was dried and exposed to a PhosphorImager screen. Transcript levels were quantified by using ImageQuant software (Molecular Dynamics). Data shown for induction of adhI transcription were calculated relative to the background level and amount of the control RNA1 product that was present in each reaction.
Potential adhI promoter sequences (Ϫ296 to ϩ14 relative to known transcriptional initiation site) were obtained by digestion of pEPS296 (6) with KpnI and HincII. This 310-bp fragment was cloned into pRKK96 digested with KpnI and StuI to generate pJWH20. The sequencing of pJWH20 with plasmid-specific primers was used to ensure the desired orientation of adhI promoter sequences relative to the SpoT40 transcription terminator on pRKK96.
RESULTS
A negative regulator of GSH-FDH expression. To search for negative regulators of GSH-FDH expression, we utilized an R. sphaeroides mutant, CYCA65R7, which contains the spd-7 allele (28) . The spd-7 allele restores photosynthetic growth to cells lacking cytochrome c 2 by increasing transcription of the adhI-cycI operon, which encodes GSH-FDH (adhI) and isocytochrome c 2 (cycI) (7) . Increased levels of isocytochrome c 2 are required for photosynthetic growth in the absence of cytochrome c 2 , so we reasoned that wild-type DNA sequences reducing adhI-cycI expression would abolish photosynthetic growth of cells containing the spd-7 allele.
To search for DNA that reduced adhI-cycI expression, a wild-type cosmid library was mobilized into cells containing an spd-7 allele (CYCA65R7), and exconjugants were scored for photosynthetic growth. One cosmid that blocked photosynthetic growth, pUI8017, was identified. To test that the loss of photosynthetic growth of cells containing an spd-7 allele was due to reduced expression of the adhI-cycI operon, we measured the levels of these gene products. To measure levels of the cycI gene product, a Western blot with CycI-specific antibody was used to determine the relative abundance of isocytochrome c 2 in aerobically grown cells (Fig. 1) . This analysis showed that there were low, but detectable, amounts of isocytochrome c 2 in both wild-type cells and cells lacking cytochrome c 2 (CYCA65). There is increased abundance of isocytochrome c 2 in cells containing the spd-7 allele, similar to results reported previously (29) . The presence of pUI8017 in the spd-7 mutant decreased the abundance of isocytochrome c 2 , providing an explanation for why the presence of this cosmid blocked photosynthetic growth of cells containing the spd-7 allele.
To provide a more accurate measure of the effects of this plasmid on adhI-cycI expression, we assayed the specific activity of GSH-FDH in crude cell extracts from these same strains. As expected from the above results, the ϳ4-fold increase in GSH-FDH-specific activities caused by the spd-7 mutation is abolished by pUI8017 (Fig. 1) . Control experiments indicate that these decreases in GSH-FDH and isocytochrome c 2 are accompanied by a reduction in the abundance of adhI-cycI mRNA (data not shown), suggesting that sequences on this plasmid are lowering transcription from the adhI promoter (6). To identify genes responsible for this decrease in adhI-cycI expression, we tested a series of plasmids derived from this cosmid for their ability to prevent photosynthetic growth of cells containing the spd-7 allele. Sequence analysis of a smaller region that prevented photosynthetic growth of cells containing an spd-7 allele revealed the presence of a potential operon (rfdRTS) predicted to encode a two-component regulatory system (RfdRS) and an additional protein (RfdT) with no predicted function (Fig. 2a) ; these correspond to open reading frames named RSP2880 to RSP2882 in the R. sphaeroides genome sequence (http://genome.ornl.gov/microbial/rsph/).
We named these genes rfdRTS (repressor of GSH-dependent formaldehyde dehydrogenase) because it appears that these gene products are negative regulators of adhI expression (see below). The predicted amino acid sequence of RfdR has significant similarity to the NarL family of response regulators, while RfdS is a member of the sensor histidine kinases. The other predicted open reading frame, RfdT, displays significant amino acid similarity to a group of hypothetical conserved proteins often found to be encoded by genes between RfdR and RfdS homologs.
RfdRTS negatively regulates adhI expression. The reduced expression of adhI-cycI when RfdRTS are present in cells containing the spd-7 allele predicts that these proteins are negative regulators of GSH-FDH expression. If RfdRTS negatively regulated adhI transcription, then the loss of RfdRS should increase adhI expression. To test this hypothesis, we constructed strains that lack RfdRTS (RfdR1, rfd-1 allele) or RfdS (RfdS1, rfd-2 allele). Expression of adhI in mutant and wild-type strains was monitored by using a previously described transcriptional fusion of adhI promoter sequences (Ϫ296 to ϩ14 relative to the transcriptional start site) to a promoterless lacZ gene on a low-copy plasmid (pTY296) (6) .
Aerobically grown wild-type cells display levels of ␤-galactosidase activity that are well above background (Table 2) , as reported previously (6) . Aerobic cells lacking RfdRTS have three-to fourfold-higher levels of ␤-galactosidase activity than wild-type cells grown in a succinate-based minimal medium. This result supports the hypothesis that RfdRTS negatively regulate adhI transcription. Cells lacking only RfdS also have ϳ3-fold-higher levels of activity from the adhI reporter gene ( Table 2 ), suggesting that the presumed kinase activity of RfdS is necessary for negative regulation of adhI transcription. The amount of adhI transcription in each of these mutants is restored to wild-type levels by introducing a plasmid (pRfd4) containing wild-type rfdRTS, confirming that the loss of RfdRTS is responsible for the increase in cells lacking either RfdRTS or RfdS ( Table 2 ). The presence of rfdRTS on this ϳ6-to 10-copy plasmid does not decrease adhI expression compared to the uninduced levels seen in the wild type (Table  2 ). This result is likely due to the fact that adhI expression is repressed in uninduced wild-type cells, so the presence of 6 to 10 copies of the genes encoding this potential negative regulator does not cause an additional decrease in adhI expression. The fact that rfdT appears to be part of an rfdRTS operon prompted us to test if RfdT has a role in regulating adhI transcription. To test this hypothesis, we monitored the activity of the adhI promoter in a strain containing an in-frame deletion in RfdT. We constructed this strain by introducing a plasmid with an in-frame deletion within rfdT (p⌬RfdT4) into cells lacking RfdRTS (RfdR1). Analysis of this strain revealed that adhI expression was similar in aerobic cells lacking RfdT to that found in wild-type cells or an RfdR mutant that contained a plasmid-encoded rfdRTS region (Table 2 ). This observation indicates that RfdT is not necessary for negative regulation of adhI transcription by RfdRS.
adhI expression in cells lacking RfdRTS or RfdS is increased by metabolic sources of formaldehyde. We know that metabolic sources of formaldehyde, like methanol, increase adhI transcription (6). To determine if rfdRTS was responsible for this increase, we measured ␤-galactosidase activity from the adhI reporter in aerobically grown wild-type cells and those lacking either RfdRTS or RfdS in the presence or absence of this metabolic source of formaldehyde. We found that adhI expression is induced ϳ15-fold by adding methanol to aerobic cells grown in a succinate-based minimal medium (Table 2) , similar to the increase reported previously (6) . In addition, we found that adhI expression in aerobic cells lacking either RfdRTS or RfdS is increased ϳ10-fold by the addition of methanol (Table 2 ). This finding indicates that RfdRTS are not essential for increased adhI transcription in the presence of metabolic sources of formaldehyde. The similar level of adhI transcription in either wild-type or RfdRTS mutant cells in the presence of metabolic sources of formaldehyde could reflect the maximal activity of the adhI promoter in vivo. In summary, these results show that RdfRS are negative regulators of adhI expression but that these proteins are not required for increased adhI transcription in response to metabolic sources of formaldehyde.
Genes encoding possible signal transduction proteins are within 8 kb of adhI. The ability of formaldehyde to increase adhI transcription in cells lacking RfdRS suggests that cells contain an additional pathway that increases activity of this promoter in the presence of formaldehyde. To search for such an additional regulator of adhI expression, we queried the R. sphaeroides genome sequence (http://genome.ornl.gov/microbial /rsph/) for gene products related to proteins that are predicted to control similar pathways in other proteobacteria.
This analysis identified additional potential regulators of adhI expression near a putative formaldehyde metabolism gene cluster (Fig. 2b) . In the region surrounding adhI-cycI are genes that could encode enzymes to oxidize methanol to formaldehyde (XoxF), periplasmic c-type cytochromes (CycI and CycB), a protein to facilitate the formation of S-hydroxymethylglutathione from formaldehyde and GSH (GfaA), and open reading frames which encode homologs of proteins of unknown function that are derived from genes typically linked to those encoding GSH-FDH family members in other eubacteria (14, 15, 17) . This region also contains genes (RSP2591 to RSP2593) predicted to encode a sensor histidine kinase, a response regulator, and a predicted integral membrane protein of unknown function (Fig. 2b) . We called these latter genes The predicted sensor histidine kinase, AfdS, has significant amino acid sequence similarity to RfdS (39% identity, 52% similarity) and to a P. denitrificans protein, FlhS (51% identity, 64% similarity), that is required to increase GSH-FDH expression (see Fig. 6 ) (17) . The potential response regulator, AfdR, is predicted to contain a C-terminal DNA-binding domain in the NarL response regulator family with significant amino acid sequence similarity to RfdR (44% identity, 59% similarity) and P. denitrificans FlhR (61% identity, 76% similarity). The predicted integral membrane protein has significant amino acid sequence similarity to RfdT and the uncharacterized gene product encoded by P. denitrificans orf2.
afdRS encodes a formaldehyde-responsive two-component regulator of adhI transcription. The similarity of AfdRS to P. denitrificans FlhRS, and the observation that flhRS mutants of this bacterium fail to activate GSH-FDH expression (17) , led us to test if these R. sphaeroides proteins regulated adhI expression. To do this, we monitored adhI expression in wild-type cells and in mutants that lack either AfdRTS (AfdR7) or AfdS (AfdS1) in the absence and presence of methanol. Expression of adhI was detectable when each of these strains was grown aerobically in a succinate-based minimal medium (Table 2) . However, the addition of 100 mM methanol failed to stimulate transcription from the adhI::lacZ fusion in cells lacking either AfdRTS or AfdS, suggesting that these proteins are required for increased adhI transcription under these conditions (Table  2) . Consistent with this notion, these defects in adhI expression are complemented by placing a wild-type copy of afdRTS in single copy in cells lacking either AfdRTS or AfdS (AfdR7-5 and AfdS1-5 [ Table 2 ]). From this result, we conclude that AfdRTS are necessary for increased adhI expression when methanol is present under aerobic conditions.
The results of previous experiments led us to propose that formaldehyde, or possibly the glutathione adduct S-hydroxymethylglutathione, is an inducer of adhI transcription (6) . Thus, the failure of methanol to stimulate adhI expression in cells lacking AfdRTS could reflect an inability of these mutants to generate formaldehyde from methanol or a defect in transcriptional control by formaldehyde. To distinguish between these possibilities, we monitored the ability of sublethal concentrations of formaldehyde to increase adhI expression. If the defect in cells lacking AfdRTS reflected an inability in generating this inducer from methanol, adhI expression should be increased by formaldehyde in these mutants. However, if formaldehyde were a potential signal molecule for AfdRTS, then cells lacking these proteins would be defective in stimulating adhI expression when formaldehyde was added.
In wild-type cells, adhI transcription is stimulated ϳ10-fold within 1.5 h after the addition of 50 M formaldehyde (Table  2) . However, there was no significant increase in adhI expression when 50 M formaldehyde was added to cells lacking either AfdRTS or AfdS (Table 2) . Placing a single copy of afdRTS in either mutant restored induction of adhI expression by formaldehyde ( Table 2 ), suggesting that AfdRS responds to this compound.
To test if AfdRS was also required for the methanol-dependent increases in adhI expression seen in cells lacking RfdRTS, we compared the ability of this compound to increase adhI expression in cells lacking both AfdRS and RfdRS (JWH1) to that of wild-type cells or stains lacking one of these pathways. In the absence of methanol, strains lacking both RfdRS and AfdRS have a level of adhI expression similar to that of wildtype cells but less than that observed in an RfdRTS mutant (Table 2 ). When either methanol or formaldehyde was added to induce adhI expression, there was no detectable increase in transcription in cells lacking both RfdRTS and AfdRTS (Table  2) . Thus, we conclude that AfdRTS is necessary for the increased adhI expression in the presence of formaldehyde that is seen in both wild-type cells and strains lacking RfdRTS.
AfdR activates adhI transcription. To test if AfdR is a direct regulator of adhI expression, we asked if this protein stimulates activity of this promoter in vitro. To accomplish this, recombinant AfdR was added to in vitro transcription reactions containing R. sphaeroides RNA polymerase holoenzyme (20 nM) and an adhI-specific template. Many response regulators activate transcription only when phosphorylated, so reactions were performed with both AfdR and protein that was incubated with acetyl phosphate prior to the in vitro transcription assays.
No adhI-specific transcript was detected in assays lacking AfdR or when up to 5 M AfdR that was not incubated with acetyl phosphate was used (Fig. 3) . However, the addition of 2 to 5 M concentrations of AfdR that was incubated with acetyl phosphate (AfdR-Pi) resulted in the production of an adhIspecific transcript of the expected size (184 nucleotides) based on the position of the known transcription initiation site rela- tive to a transcription terminator on the plasmid template (Fig.  3) . Of equal significance, the addition of acetyl phosphatetreated AfdR caused no detectable increase in the abundance of control RNA1 transcript that is contained on the plasmid template, suggesting that this increase in adhI expression is not due to a general increase in transcription.
We are unable to quantify the ability of acetyl phosphatetreated AfdR to stimulate adhI transcription because there is no detectable transcript in the absence of this protein or when untreated samples of this protein are used. However, there is a ϳ17-fold increase in adhI transcript levels when reactions containing 2 M AfdR that had been treated with acetyl phosphate were compared to those where 0.5 M AfdR was treated under identical conditions, and there is a ϳ22-fold increase in transcript levels when 5 M AfdR that was treated with acetyl phosphate was used. These results demonstrate that AfdR is a direct activator of adhI transcription and they suggest that this protein, like other members of the NarL family of response regulators, must be phosphorylated in order to activate transcription.
RfdR binds the adhI promoter. The increased adhI promoter activity in cells lacking RfdR suggested that this protein was a repressor of GSH-FDH expression (see above). To provide evidence supporting this hypothesis, we tested the ability of RfdR to interact with the adhI promoter by a gel mobility shift assay. To accomplish this, we used a truncated form of RfdR that contains only its putative C-terminal DNA binding domain (RfdR-CTD). Control experiments indicate that that half-life of 32 P-labeled full-length RfdR is less than 1 min (data not shown), suggesting that it would be difficult to maintain phosphorylation of full-length RfdR during the time needed to observe any interactions with adhI promoter sequences by a gel mobility shift assay. Thus, the use of RfdR-CTD meant that this protein should not need to be treated with acetyl phosphate in order to observe an interaction with the adhI promoter.
A DNA fragment containing adhI promoter sequences that extend from Ϫ296 to ϩ180 relative to the known adhI transcription start site was incubated with purified recombinant RfdR-CTD prior to separating any DNA-protein complexes from promoter DNA on a 6% polyacrylamide gel. A shift in the mobility of the adhI promoter fragment can be seen when 0.5 M RfdR-CTD is added to the reaction (Fig. 4) . The amount of this slower-migrating species increases when 1.0 M RfdR-CTD is present. This finding indicates that RfdR-CTD is capable of interacting with the adhI promoter at micromolar concentrations. This interaction between RfdR-CTD and the adhI promoter appears to be specific due to the fact that a 300-fold excess of a nonspecific competitor was present in these reactions.
RfdR is a direct inhibitor of adhI transcription. Since RfdR-CTD binds the adhI promoter, we wanted to test if RfdR-CTD could inhibit adhI transcription in vitro. It was not feasible to test the ability of RfdR alone to inhibit adhI transcription since no product was detectable from this promoter in the absence of acetyl phosphate-treated AfdR (Fig. 3) . However, the ability of acetyl phosphate-treated AfdR to stimulate adhI transcription in vitro provided a way to test if RfdR acted directly to repress transcription from this promoter. To test this hypothesis, we used RfdR-CTD, which was deleted in the N-terminal response regulator domain, and its presumed oligomerization region in order to minimize the potential for formation of mixed oligomers between the related AfdR and RfdR proteins in vitro. The use of RfdR-CTD also meant that this protein should not need to be treated with acetyl phosphate in order to observe an affect on adhI transcription in vitro.
To test if RfdR was a direct inhibitor of adhI transcription, we monitored the abundance of this transcript when increasing amounts of RfdR-CTD (0.5 to 4 M) were added to multipleround transcription reactions containing R. sphaeroides RNA polymerase holoenzyme (95 nM), an adhI-specific template, and AfdR (2 M) that was treated with acetyl phosphate (Fig.  5) . As expected, pretreatment of AfdR with acetyl phosphate prior to the assay resulted in the accumulation of an adhI transcript. There was a concentration-dependent decrease in the amount of the adhI transcript when increasing amounts of RfdR-CTD were present in the reactions. This negative effect of RfdR-CTD did not appear to reflect a general decrease in transcription since the addition of this protein did not reduce the amount of the control RNA1 transcript in a concentrationdependent manner (Fig. 5) . If one measures the amount of adhI transcript present at different concentrations of RfdR-CTD relative to the level of RNA1 transcript that is present in each of these assays, ϳ2 M RfdR-CTD is sufficient to reduce the amount of this product by 50% (Fig. 5) . By comparing the ability of RfdR-CTD to interact with adhI promoter DNA (Fig. 4) and its ability to inhibit transcript production from this promoter (Fig. 5 ), it appears that the apparent affinity of this truncated protein is in the micromolar range. Thus, we conclude that RfdR is a direct inhibitor of adhI transcription because it binds to this promoter and can act as a repressor of GSH-FDH expression.
DISCUSSION
The ability to metabolize formaldehyde and regulate the expression of genes required for its oxidation is likely to be   FIG. 4 . RfdR-CTD binds to adhI promoter sequences. The amounts of RfdR-CTD added to the binding reaction are indicated above the lanes. The arrows indicate the migration position of the adhI promoter fragment and migration position of the presumed complex between DNA and RfdR-CTD. In this assay, 2 ng of end-labeled DNA (extending from Ϫ296 to ϩ180 relative to the adhI transcription initiation site) was present in each reaction (6 Our results predict that one regulator of adhI expression, RfdRS, is a repressor of adhI expression, while the other, AfdRS, activates adhI transcription. Both systems contain a predicted sensor histidine kinase (RfdS and AfdS) and a response regulator (RfdR and AfdR). The R. sphaeroides genome sequence predicts that AfdRS is encoded within a putative five-gene operon that includes afdRTS, RSP2594, and RSP2595. The function of AfdT and the latter two genes are unknown, but homologs exist in P. denitrificans (17) . If these five genes are cotranscribed from one promoter, RSP2594 and RSP2595 are not necessary for AfdRS function under the conditions tested since afdRTS complements cells containing a polar insertion in afdR.
Features of RfdRTS and AfdRTS. The deduced amino acid sequence of AfdS and RfdS predict that they are soluble sensor histidine kinases. Of the histidine kinases that have been described, RfdS and AfdS display the greatest similarity to the presumed sensor in a pathway that activates P. denitrificans GSH-FDH expression, FlhS (17) . The C termini of RfdS, AfdS, and FlhS are each predicted to also contain an additional receiver domain that is found on the N terminus of response regulators (RfdS residues 618 to 720 and AfdS residues 350 to 470). The predicted presence of a receiver domain in these presumed sensors suggests that these are hybrid histidine kinases that use multiple phosphotransfer reactions as part of their signaling pathway. AfdS and FlhS each have a relatively small N-terminal sensor domain (residues 1 to 83) compared to that of RfdS (residues 1 to 373) (Fig. 6) . The possible significance of this larger sensor domain in RfdS is presented below.
The amino acid sequence of RfdR and AfdR predicts that they each contain typical N-terminal receiver domains and C-terminal helix-turn-helix motifs related to the DNA binding domain of NarL. AfdR appears to require phosphorylation to activate adhI transcription. This is consistent with the behavior of the related E. coli NarL protein and many other response regulators (3) . It is also likely that the related RfdR protein also requires phosphorylation to interact with DNA since it is also a response regulator in the NarL family. It is unknown where either AfdR or RfdR binds within the adhI promoter and whether they contain one or multiple binding sites as is the case for NarL at some promoters (12) . There is also considerable amino acid sequence identity in the C-terminal domains of AfdR and RfdR, so it may be possible that they have similar or overlapping target sites for DNA binding.
RfdT and AfdT are not related to any characterized proteins, but hydropathy analysis (using the Kyte-Doolittle scale [http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html]) indicates that they contain at least one transmembrane domain. An in-frame deletion in R. sphaeroides rfdT had no detectable effect on adhI expression in the absence or presence of known inducers. Therefore, a role for AfdT/RfdT in R. sphaeroides and the P. denitrificans homolog (Orf2) remains to be determined.
Multiple pathways control adhI expression. Transcription of R. sphaeroides adhI is induced by formaldehyde or several metabolic sources of this compound (6) ganisms which appear to contain only an AfdRS or RfdRS system. In conclusion, we have identified multiple two-component systems that directly regulate expression of the R. sphaeroides GSH-FDH structural gene adhI. One of these systems, AfdRS, is a direct activator of adhI transcription that appears to respond to an intermediate in formaldehyde oxidation, while RfdRS is a direct negative regulator of GSH-FDH expression in response to an unknown signal. These observations indicate that regulation of GSH-dependent formaldehyde oxidation in R. sphaeroides is an intricate process with multiple two-component systems that could each respond to different physiological signals. The AfdRS system shares similarities with other two-component regulators, but this is the first report of a transcription factor acting directly to regulate transcription of a formaldehyde-inducible gene. We are now in a position to determine how AfdRS senses signals from formaldehyde metabolism and regulates genes needed for metabolism of this compound. Additional work to identify the signal that controls RfdRS function will characterize the role of this two-component system and could help elucidate additional roles for GSH-FDH in cells.
